Maxine S. Emmett

829 total citations
14 papers, 636 citations indexed

About

Maxine S. Emmett is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Maxine S. Emmett has authored 14 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Biomedical Engineering. Recurrent topics in Maxine S. Emmett's work include Lymphatic System and Diseases (6 papers), Angiogenesis and VEGF in Cancer (5 papers) and Optical Coherence Tomography Applications (3 papers). Maxine S. Emmett is often cited by papers focused on Lymphatic System and Diseases (6 papers), Angiogenesis and VEGF in Cancer (5 papers) and Optical Coherence Tomography Applications (3 papers). Maxine S. Emmett collaborates with scholars based in United Kingdom, United States and Switzerland. Maxine S. Emmett's co-authors include David O. Bates, Rowan Pritchard‐Jones, Antonio Orlando, H Rigby, H K Genant, Guerdon Greenway, A C Brower, Daniel K. Resnick, P Haghighi and P.S. Mortimer and has published in prestigious journals such as Cancer Research, Oncogene and Radiology.

In The Last Decade

Maxine S. Emmett

14 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maxine S. Emmett United Kingdom 12 287 227 170 126 107 14 636
Silvia Giunco Italy 17 307 1.1× 332 1.5× 222 1.3× 111 0.9× 121 1.1× 37 880
Chu‐Myong Seong South Korea 14 155 0.5× 254 1.1× 57 0.3× 90 0.7× 135 1.3× 35 691
Morito Monden Japan 14 145 0.5× 301 1.3× 98 0.6× 137 1.1× 51 0.5× 19 635
Eugene A. Choi United States 10 257 0.9× 137 0.6× 73 0.4× 137 1.1× 69 0.6× 17 491
J A Koedam Netherlands 14 80 0.3× 219 1.0× 100 0.6× 62 0.5× 182 1.7× 19 1.1k
Oliver Wengert Germany 8 98 0.3× 148 0.7× 82 0.5× 49 0.4× 142 1.3× 10 501
Markus W. Büchler Switzerland 7 285 1.0× 155 0.7× 33 0.2× 243 1.9× 68 0.6× 8 514
N. Stafford United Kingdom 15 233 0.8× 250 1.1× 31 0.2× 199 1.6× 74 0.7× 44 716
Claudia Parisi Italy 18 342 1.2× 193 0.9× 47 0.3× 369 2.9× 145 1.4× 47 1.2k
A Camagna Italy 16 96 0.3× 247 1.1× 58 0.3× 38 0.3× 165 1.5× 38 656

Countries citing papers authored by Maxine S. Emmett

Since Specialization
Citations

This map shows the geographic impact of Maxine S. Emmett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxine S. Emmett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxine S. Emmett more than expected).

Fields of papers citing papers by Maxine S. Emmett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxine S. Emmett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxine S. Emmett. The network helps show where Maxine S. Emmett may publish in the future.

Co-authorship network of co-authors of Maxine S. Emmett

This figure shows the co-authorship network connecting the top 25 collaborators of Maxine S. Emmett. A scholar is included among the top collaborators of Maxine S. Emmett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxine S. Emmett. Maxine S. Emmett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Aljasir, Mohammad Abdullah, et al.. (2024). The ERK5 pathway in BRAFV600E melanoma cells plays a role in development of acquired resistance to dabrafenib but not vemurafenib. FEBS Letters. 598(16). 2011–2027. 7 indexed citations
2.
Alghanem, Ahmad F., Maxine S. Emmett, Mohammad Abdullah Aljasir, et al.. (2017). RCAN1.4 regulates VEGFR-2 internalisation, cell polarity and migration in human microvascular endothelial cells. Angiogenesis. 20(3). 341–358. 43 indexed citations
3.
Wilkie, Mark D., Maxine S. Emmett, Steven Lane, et al.. (2014). Relative expression of vascular endothelial growth factor isoforms in squamous cell carcinoma of the head and neck. Head & Neck. 38(5). 775–781. 5 indexed citations
4.
Emmett, Maxine S., et al.. (2011). Angiogenesis and melanoma - from basic science to clinical trials.. PubMed. 1(7). 852–68. 46 indexed citations
5.
Roussigné, Myriam, Maxine S. Emmett, Virginie Carrière, et al.. (2010). Chemotrap-1: An Engineered Soluble Receptor That Blocks Chemokine-Induced Migration of Metastatic Cancer CellsIn vivo. Cancer Research. 70(20). 8138–8148. 20 indexed citations
6.
Emmett, Maxine S., et al.. (2010). CCR7 Mediates Directed Growth of Melanomas Towards Lymphatics. Microcirculation. 18(3). 172–182. 37 indexed citations
7.
Emmett, Maxine S., Kirsty E. Symonds, H Rigby, et al.. (2010). Prediction of melanoma metastasis by the Shields index based on lymphatic vessel density. BMC Cancer. 10(1). 208–208. 24 indexed citations
8.
Fiedler, Ulrike, Sven Christian, Stefanie Koidl, et al.. (2006). The Sialomucin CD34 Is a Marker of Lymphatic Endothelial Cells in Human Tumors. American Journal Of Pathology. 168(3). 1045–1053. 71 indexed citations
9.
Emmett, Maxine S., H Rigby, P.S. Mortimer, et al.. (2006). Chemokine-mediated migration of melanoma cells towards lymphatics – a mechanism contributing to metastasis. Oncogene. 26(21). 2997–3005. 133 indexed citations
10.
Foster, Rebecca R., Simon C. Satchell, Maxine S. Emmett, et al.. (2006). VEGF-C promotes survival in podocytes. American Journal of Physiology-Renal Physiology. 291(1). F196–F207. 43 indexed citations
11.
Peterson, V. M., Maxine S. Emmett, F A Moore, et al.. (1989). Total enteral nutrition versus total parenteral nutrition after major torso injury: Attenuation of hepatic protein reprioritization. Journal of Critical Care. 4(2). 148–148. 82 indexed citations
12.
Emmett, Maxine S., Alpha A. Fowler, Thomas M. Hyers, & Alfred J. Crowle. (1987). Crossed Immunoelectrophoretic Analysis of ARDS Lavage Proteins. Experimental Biology and Medicine. 184(1). 83–91. 12 indexed citations
13.
Emmett, Maxine S., Janet L. Miller, & Alfred J. Crowle. (1987). Protein Abnormalities in Adult Respiratory Distress Syndrome, Tuberculosis, and Cystic Fibrosis Sera. Experimental Biology and Medicine. 184(1). 74–82. 27 indexed citations
14.
Resnick, Daniel K., Guerdon Greenway, H K Genant, et al.. (1982). Erdheim-Chester disease.. Radiology. 142(2). 289–295. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026